The report this homepage got.
On August 10, 2026, I ran juliedx.com through LandingPageDx — full-page screenshots of this homepage, top to bottom, through the same tool you’d use. This is the report it returned, word for word, in the same interface you’d get. Open the fixes, read the dimension grades, and ask Julie up to two questions about the read.
Yes, it grades its own maker, and it still found real fixes.
Strong page. Proof needs names.
HOMEPAGE
This page knows exactly what it does and shows its work in a way most competitors can't match. The one thing holding it back is anonymous social proof sitting where attributed outcomes would close the deal.
This page is close. These fixes are what get it there.
Julie's Read
You built a tool that diagnoses vague proof, then put three anonymous quotes on your own page. The hero gets the product across clean, but it opens with what the tool does instead of the moment the reader is in right before they need it.
Priority Fixes
- 1. Your testimonials have no names. That makes them almost worthless. [High · Quick Win effort]
Fix: Add a name, role, and company to each of the three existing testimonials. If you don't have permission to use real names, replace the quotes with ones you do have permission to attribute. An anonymous quote from a real person you can't name is less persuasive than one attributed quote from someone you can.
Paste-ready copy: Format each testimonial as: [Quote text] — [First Name Last Name], [Title], [Company or 'Freelance Strategist' or equivalent]. Example: 'Umm.. this diagnostic tool is scary good!' — Sarah K., Marketing Manager, [Company]
Why it matters: Your page earns trust through specificity everywhere else, then hands it off to three floating quotes no one can verify. Every visitor who notices the missing attribution subtracts a point of credibility right before they decide whether to run their first diagnostic.
Fact: Spiegel Research Center retail behavioral research found that attributed, verified proof improved purchase odds by an additional 15% on top of the baseline lift from showing social proof at all. The mechanism is attribution: proof that can be traced to a real, named source is more persuasive than anonymous praise. (Spiegel Research Center / Northwestern University)
- 2. The hero talks about the tool. It should talk to the reader first. [High · Quick Win effort]
Fix: Rewrite the hero headline to open in the reader's headspace before naming what JulieDx does. The current headline is clean and specific, but it leads with product action. One line above it that names the situation the reader is already in would make every subsequent sentence land harder.
Paste-ready copy: Option A — New eyebrow label (add above current headline): 'You sent it. It didn't work. Here's why.' | Option B — Replace current headline: 'Your page isn't converting. Here's exactly why.' | Then keep the current subhead: 'It grades the work, names the real problem, and ranks the fixes. In under two minutes.'
Why it matters: Cold visitors spend the first few seconds confirming they're in the right place. A headline that starts with their situation ('it didn't work') triggers that confirmation faster than one that starts with the product's action. This is what closes the gap between a B+ page and an A.
- 3. The audience-version selector shows up too late. [High · Quick Win effort]
Fix: Move the 'You're on the in-house marketer version' copy and the two alternate-version buttons into the hero section, below the three diagnostic CTAs. Right now a Fractional CMO or SMB owner reads the in-house marketer version of the hero before discovering they can switch. A one-line anchor near the top solves this without a redesign.
Paste-ready copy: Add below the three CTA buttons in the hero, before 'FIRST RUN FREE': 'This is the in-house marketer version. | See the Fractional CMO/Agency version | See the SMB version' — style as small text links, not buttons, so they don't compete with the primary CTAs.
Why it matters: You built three versions of this page, which is exactly the right instinct. But the visitor has to get halfway down the page before they find out the other versions exist. Moving the signal to the hero means every visitor self-routes before they read the wrong pitch.
- 4. The 'Pick your diagnostic' section buries the free trial line. [Medium · Quick Win effort]
Fix: The 'FIRST RUN FREE. FREE 3-DAY TRIAL. THEN $19.99/MO.' line appears only in the hero. When a visitor scrolls to the 'Pick your diagnostic' section and sees 'RUN IT' links, the pricing reassurance isn't visible. Add a single pricing line beneath each product card's CTA.
Paste-ready copy: Below each 'RUN IT →' link: 'First run free. No card required.' — small, low-contrast text, same styling as the hero pricing line.
Why it matters: A visitor who scrolls to the product picker without the free trial framing in view is making a commitment decision with no price context visible. Repeating that one line at the point of action removes a hesitation that costs you nothing to address.
What's Working
- The 'This page was diagnosed with my own tools' section is the strongest trust move on the page. It turns the product's credibility claim into a live demonstration and gives a skeptical first-time visitor a reason to believe the tool is real before they commit a single click.
- Three distinct CTAs in the hero ('Grade my page,' 'Grade my email,' 'Grade my mail piece') solve a real routing problem without creating confusion. Each visitor self-selects the asset they actually have, which lowers friction at exactly the right moment.
- The 'Why not just ask Claude?' comparison section is smart positioning. It names the real objection a modern marketer has and answers it with a structural argument, not a feature list. That's confident, specific, and genuinely differentiating.
Report Card
| Dimension | Score | Grade | Finding |
|---|---|---|---|
| Strategy & Positioning | 88 | B+ | Julie's read: The hero headline names a customer problem directly ('Find out why your page, email, or mail isn't converting') and the audience is identifiable in the first screen. A direct competitor couldn't put their logo on this page without significant edits because the self-diagnosis demonstration and the specific rubric framing are genuinely ownable. The one crack is that the headline opens with the product action rather than the moment the reader is already living in before they know JulieDx exists. Fix: The headline is product-first rather than reader-situation-first, which costs a beat of recognition for cold visitors. |
| Copy & Messaging | 86 | B | Most claims are specific and mechanism-focused: 'The same rubric every time,' 'A verdict you can forward,' 'In under two minutes.' The hero answers what this is, who it's for, and what to do. The CTA copy in the hero is action-and-asset-oriented, which is strong. The gap is the three testimonials below the fold, which are quoted outcomes but carry no attribution, reducing the specificity the rest of the page earns. Fix: The testimonials are the only unspecific copy block on an otherwise sharp page, and they land in a high-attention proof zone. |
| Persuasion & Trust | 82 | B- | The sample report section is the strongest proof element on the page because it is visible, specific, and shows the product doing exactly what it promises. The three testimonials in the 'After they run it' section are positive but anonymous, no names, no titles, no companies, which limits their persuasive weight. The named credential ('15 years at Macy's, CVS, Elevance Health, and GoodRx') is specific authority done right. Fix: Anonymous testimonials are the weakest proof format available, and they're the only social proof from actual users on the page. |
| UX & Layout | 90 | A- | The primary CTA buttons are visible above the fold on desktop and appear sized and spaced for mobile visibility. The page body has no competing in-body CTAs pulling toward different offers in the hero zone. The three-CTA structure (page, email, mail piece) functions as a single conversion action with self-routing, not as competing destinations. The 'Or read a real report first' secondary CTA is well-handled as a softer on-ramp rather than a competing exit. Fix: The audience-version routing ('You're on the in-house marketer version') appears mid-page, after the hero, which means cold visitors read the wrong-version content before discovering they can switch. |
| Trust & Credibility | 91 | A- | Julie's read: The credential anchor is specific and named: Macy's, CVS, Elevance Health, GoodRx, 15 years. The FAQ addresses 'Who built this and why should I trust it?' and 'What do you do with my content?' directly, which handles the two trust questions a cautious marketer would actually ask. Privacy Policy and Terms of Use are in the footer, their correct home. The 'first run free, no card needed' language near the primary CTA removes the commitment-stage friction that anonymous tools often create. Fix: No visible attribution on the testimonial quotes means the user-voice proof can't be verified, which a skeptical visitor will notice. |
Audience
Your page says 'in-house marketer.' The person landing here might be someone else entirely.
Who this page appears to be talking to: In-house marketers and small business owners who have a page or email that isn't converting and need a structured diagnosis they can act on and defend.
Who may actually be landing here: The page explicitly acknowledges three audience versions (in-house marketer, Fractional CMO/Agency, SMB) and tells visitors they're on the in-house marketer version. That's strong self-awareness. The gap is that visitors who arrive cold from non-branded search or word of mouth don't get routed to their version before reading. They have to discover the other versions mid-page.
The 'This page was diagnosed with my own tools' section is the strongest trust move on the page. It turns the product's credibility claim into a live demonstration and gives a skeptical first-time visitor a reason to believe the tool is real before they commit a single click.
Three distinct CTAs in the hero ('Grade my page,' 'Grade my email,' 'Grade my mail piece') solve a real routing problem without creating confusion. Each visitor self-selects the asset they actually have, which lowers friction at exactly the right moment.
The 'Why not just ask Claude?' comparison section is smart positioning. It names the real objection a modern marketer has and answers it with a structural argument, not a feature list. That's confident, specific, and genuinely differentiating.
